Similarly, mammalian galectin-9 suppressed binding of HA to CD44 on melanoma and colon cancer cell lines resulted in suppression of both attachment and invasion of tumor cells by inhibiting their binding of adhesive molecules to ligands on vascular endothelium and the extracellular matrix (89). This evidence concerns the gene LGALS9 and melanoma.